TwoCells Co., Ltd.

Industry

  • Medical Devices
    • Infusion Therapy Equipment and Supplies
    • Implantable Devices
    • Infection Control-Sterilization
    • Biomaterials
    • Consumables, Central Supplies
    • Rehabilitation Equipment and Devices
    • Radiofrequency Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
    • Laser
    • Monitoring Equipment & Devices
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Distributors

Other Names/Subsidiaries

  • Two Cells
See more in Biomedtracker

Latest on TwoCells Co., Ltd.

Scrip

Asia Deal Watch: Otsuka’s Taiho Licenses LSD1 Inhibitor Rights To Benz

 
• By Joseph Haas, Lisa Takagi, Jung Won Shin, Vibha Ravi, and Sushmita Panda

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Taiho Sends Benz LSD1 Inhibitor Fo

Scrip

Pipeline Watch: Phase III Progress With Avelumab, Brimapitide, Inhaled Amikacin

 
• By John Davis

The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer

In Vivo

Biopharma Quarterly Dealmaking Statistics, Q2 2016

 
• By Maureen Riordan and Amanda Micklus

Financings Biopharma firms raised a total of $4.8 billion in financing in the second quarter of 2016, a 16% decrease in value from Q1's $5.8 billion. Follow-on public offerings and early-stage venture